Leave Your Message

Submit An Free Inquiry

Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

AI Helps Write
AI Helps Write

Acute Lymphoblastic Leukemia(T-ALL)-03

Te manawanui: Huang XX

Ira tangata:Tane

Te tau: 42 tau

Nationality: Hainamana

Te tātaritanga:Acute Lymphoblastic Leukemia(T-ALL)

    Ahuatanga Take:

    - Tatautanga: kano kano lymphoblastic pūtau T whakapeka

    - Te timatanga me nga tohu: Paenga-whāwhā 2020, ka puta te mangere, te ngenge, me te kiri toto. I whakamohiotia he kanisa lymphoblastic T-cell whakapeka na roto i te whakamatautau MICM hinu hinu wheua.

    - Maimoatanga Tuatahi: Kua tutuki i te murunga katoa (CR) i muri mai i te tikanga whakamohoatanga a te VDCLP, whai muri i nga huringa e 2 o te whakamaarama haumanu.

    - Hūrae 19, 2020: I whakawhiwhia ki te whakawhiti i te pūtau pūtau hematopoietic allogeneic mai i tetahi kaituku wahine (HLA 5/10 A kaituku A). Ko te tikanga whakamaarama ko te katoa o te irradiation tinana (TBI), cyclophosphamide (CY), me te etoposide (VP-16). Ko nga pūtau kakau i te taha o te taha i whakauruhia i te Hūrae 24, me te whakaora i te granulocyte i te ra +10 me te whakauru platelet i te ra +13. Whai muri i nga mahi a te hunga mate waho.

    - Hui-tanguru 25, 2021: I kitea te hokinga mai o te hinu wheua i te wa e whai ana.

    - Maimoatanga: I timata te rongoa thalidomide waha.

    - Maehe 8: I whakauruhia ki to maatau hohipera.

    - Bone Marrow Morphology: 61.5% nga pupuhi.

    - Te Whakar

    - Immunophenotyping: 35.25% nga pūtau e whakaatu ana i te CD99, CD5, CD3dim, CD8dim, CD7, cCD3, CD2dim, HLA-ABC, cbcl-2, CD81, CD38, e tohu ana i nga lymphocytes T korekore.

    - Tirohanga Chromosome: 46, XX [9].

    - Ira Whakakotahitanga Leukemia: SIL-TAL1 ira whakakotahitanga pai; ine ine: SIL-TA.

    - Huringa Tumor Toto: He kino.

    - Chimerism Analysis (post-HSCT): E 45.78%.

    - Poutū-te-rangi 11: Kohinga o nga lymphocytes toto peripheral autologous mo te ahurea pūtau CD7-CART.

    - Maimoatanga: VILP (VDS 4mg, IDA 10mg, L-asparaginase 10,000 IU qd x 4 ra, Dex 9mg q12h x 9 ra) te tikanga kua honoa me te thalidomide hei whakahaere i te puku.

    - Maehe 19: FC regimen chemotherapy (Rewharewha 50mg x 3 ra, CTX 0.4gx 3 ra).

    - Poutū-te-rangi 24 (i mua i te whaowhia): Ko te ahua o te hinu wheua i whakaatu i te hyperplasia o te reanga V, me te 22% nga pupuhi.

    - Bone Marrow Rere Cytometry: 29.21% ngā pūtau (o ngā pūtau karihi) e whakaatu ana i te CD3, CD5, CD7, CD99, e whakaatu ana i tetahi wahanga cCD3, e tohu ana i nga pūtau T pakeke kore.

    - Ira Whakakotahitanga SIL-TAL1 Ine: 1.913%.

    25dho

    Maimoatanga:
    - Poutū-te-rangi 26: Te whaowhia o nga pūtau CD7-CART autologous (5*10^5/kg)
    - CAR-T Paanga taha: CRS grade 1 (kirika), kaore he neurotoxicity
    - Paenga-whāwhā 12 (Ra 17): Ko te whai i muri i whakaatu i te ahua o te hinu wheua i roto i te murunga, karekau he pūtau pakeke kino kino i kitea e te cytometry rere, me te ine ira whakakotahitanga SIL-TAL1 (STIL-SCL) i te 0

    26i6g

    whakaahuatanga2

    Submit An Free Inquiry

    Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

    AI Helps Write